The World Health Organization (WHO) will begin clinical trials next week in the Democratic Republic of Congo to evaluate two potential treatments for the Ebola virus. This decision comes as the ongoing epidemic continues to spread despite increased efforts to contain it. The trials aim to assess the effectiveness of these medications in combating the disease. Anadolu Agency reports that the WHO announced the initiative on Wednesday. This represents a significant step in the search for effective Ebola therapies. The trials will be crucial in determining which treatments offer the best chance of survival for those infected. The outbreak remains a serious public health concern in the region.